Blog
RSS FeedPosted by Michael Wonder on 17 Dec 2018
Medicines Australia welcomes the Government’s recognition of the importance of medicines
17 December 2018 - Medicines Australia welcomes today’s Mid-Year Economic and Fiscal Outlook, announced by Treasurer the Hon. Josh Frydenberg ...
Posted by Michael Wonder on 13 Dec 2018
The little-known way pharma companies hook people on their costly drugs
12 December 2018 - Kip Burgess was relieved last year when pharmaceutical giant Amgen overnighted him a $2,976 check to ...
Posted by Michael Wonder on 12 Dec 2018
FDA takes aim at pharma’s biosimilar-delaying tactics
12 December 2018 - Ever-rising cost of insulins also to be targeted. ...
Posted by Michael Wonder on 12 Dec 2018
Bernie Sanders' drug price controls would stifle medical innovation
11 December 2018 - Senator Bernie Sanders and Representative Ro Khanna recently proposed bills that would impose price controls on ...
Posted by Michael Wonder on 11 Dec 2018
The drug industry is headed back to Congress to make its case. Will Democrats keep the door open?
10 December 2018 - With annual revenues of roughly $450 million and an army of some 160 lobbyists, PhRMA has ...
Posted by Michael Wonder on 10 Dec 2018
Pharma calls for more detail on plan for post Brexit medicines access
10 December 2018 - The pharmaceutical industry is calling on the government to urgently provide more detail on how it ...
Posted by Michael Wonder on 09 Dec 2018
Congress to drug makers: why stock buybacks over lowered drug prices?
6 December 2018 - Democratic law makers criticise big pharmaceutical firms for use of tax savings, threaten hearings. ...
Posted by Michael Wonder on 09 Dec 2018
How perceptions of high drug prices do not necessarily match reality
6 December 2018 - The U.S. public apparently believes that drug prices are too high. At the same time, they ...
Posted by Michael Wonder on 08 Dec 2018
Patent abuse is driving up drug prices. Just look at Lantus.
7 December 2018 - A rare point of consensus following the midterm elections is that Americans are adamant about lowering ...
Posted by Michael Wonder on 06 Dec 2018
Pfizer and Merck are raising drug prices again, showing that their price cuts were just a sham to mollify Trump
6 December 2018 - It’s hard to believe that anyone was taken in this summer when a handful of drug ...
Posted by Michael Wonder on 06 Dec 2018
FDA publishes post CRL guidance for generic companies
4 December 2018 - The US FDA has published final guidance for the generics industry on post-complete response letter meetings. ...
Posted by Michael Wonder on 05 Dec 2018
NHS to save £1 billion on its medicines bill in 2019
5 December 2018 - The NHS is expected to save around £930 million on its medicines bill across the UK ...
Posted by Michael Wonder on 03 Dec 2018
Recognition where it’s due: the Access to Medicines Index and the pharma industry
3 December 2018 - Former CEO of Medicines Australia Brendan Shaw says Bill Gates is correct when he says pharmaceutical ...
Posted by Michael Wonder on 03 Dec 2018
Canadian R&D-to-sales ratio for brand-name drug companies less than half of 10% commitment
3 December 2018 - USMCA concessions latest hit to Canadian prescription drug costs. ...
Posted by Michael Wonder on 01 Dec 2018
Novartis CEO Vas Narasimhan on the price of gene therapies: 'it's a challenge we have to solve'
29 November 2018 - In May Novartis announced that it had acquired the gene therapy pioneer AveXis in a $8.7 ...